KOLON Biotech has more than
20 years of experiences
in the cell and gene therapy.
History
-
2000
Established TissueGene Asia Ltd. in Korea
-
2006
Changed the company name to Kolon Life Science, Inc.
-
2009
IPO (Korea, KOSDAQ)
-
2014
Constructed Bio Plant B1
-
2017
Started commercial manufacturing of cell and gene therapy products
-
2019
Completed Bio cGMP (planned) Plant B2
-
2020
Split off KOLON Life Science to KOLON Biotech
Location
-
SeoulKOLON One & Only Tower, 110, Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea
-
KOLON One & Only Tower, 110, Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea
-
Chungju[Plant] 54-1, Gieopdosi 1-ro, Daesowon-myeon, Chungju-si, Chungcheongbuk-do, Republic of Korea
-
[Plant] 54-1, Gieopdosi 1-ro, Daesowon-myeon, Chungju-si, Chungcheongbuk-do, Republic of Korea
Brochure
Highly-Skilled Teams
Skilled Teams
We have CDMO employees with extensive experiences in analytical, formulation, manufacturing and regulatory activities in the biopharmaceutical area. We maintain a diverse workforce mix for each function.
